To our knowledge, no other work studied the effects of ketamine on NMDA receptor subunits 5 weeks post its injection in adults; further work is needed to validate our observation of long-lasting reduction of prefrontal NR2A mRNA levels, which can have important medical implication for the use of ketamine for the treatment of depression. The gene discussed is GRIN2A; the disease is depressive disorder.